PanCAN Chief Scientific & Medical Officer Dr. Anna Berkenblit looks back on the progress made toward better understanding and ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

Experts believe poor diet, more ultra-processed foods, obesity and a lack of exercise are playing a role. A long-awaited ...

HistoSonics, the developer and manufacturer of the Edison® Histotripsy System, announced today the first patients with pancreatic tumors were successfully treated in the company sponsored GANNON trial ...

Feasibility Trial Evaluates Safety of Histotripsy to Destroy Pancreatic Tumors MINNEAPOLIS--BUSINESS WIRE--HistoSonics, the developer and ...

ImmunityBio, Inc. (IBRX), an immunotherapy company, on Wednesday priced its previously announced underwritten public offering of ...

From climate disasters to political unrest—and everything in between—2024 was a challenging year already, but for certain ...

Recent cancer treatment breakthroughs include FDA approvals for zenocutuzumab and durvalumab, and sacituzumab tirumotecan gained breakthrough therapy status. In addition, sonodynamic therapy shows ...

Reolysin is an oncolytic virus commercialized by Oncolytics Biotech, with a leading Phase II program in Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer).

Lung cancer, long known to affect smokers, is seeing a significant rise in people who do not smoke, said doctors on Monday, ...

Lung cancer, long known to affect smokers, is seeing a significant rise in people who do not smoke, said doctors on Monday ...

ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, today announced the pricing of its previously announced ...